Cognitive Reflection Test (CRT) Practice

What should a client report while taking Donepezil?

1. Weight loss

2. Increased energy

3. Light stools and jaundice

4. Improved memory

The correct answer is: Light stools and jaundice

When considering what a client should report while taking Donepezil, it's important to understand the potential side effects and adverse reactions to this medication. Donepezil is primarily used to treat symptoms of Alzheimer's disease by improving cognitive function, but it can also lead to certain issues that need to be monitored. Light stools and jaundice indicate potential liver problems, which could manifest as changes in stool color and noticeable yellowing of the skin or eyes. These symptoms warrant immediate medical attention, as they can be signs of hepatotoxicity – a risk associated with many medications, including Donepezil. Monitoring for these signs is crucial, as it allows for early intervention and management of any serious side effects. In contrast, reporting weight loss, increased energy, or improved memory may not be directly associated with the primary concerns when initiating treatment, nor do they indicate acute side effects that require urgent evaluation. While some clients may experience improved cognitive function, it’s essential to differentiate that from the serious implications of jaundice and abnormal stool coloration. Therefore, the focus on light stools and jaundice as a reporting point emphasizes the necessity of monitoring potential liver-related side effects when on Donepezil.